This PedsCases Note provides a one-page infographic on the pathophysiology, classification, investigations, and management of STEC hemolytic uremic syndrome. It was created by Katharine Jensen, a pediatrics resident at the University of Alberta, in collaboration with Dr. Sara Rodriguez Lopez, an Assistant Professor & Pediatric Nephrologist at the Stollery Children's Hospital and University of Alberta.

Click on the image below for the full-screen PDF handout.

Related Content

• Podcast: Hemolytic Uremic Syndrome

References

1. Harkins VJ, McAllister DA & Reynolds BC. Shiga-Toxin E. coli Hemolytic Uremic Syndrome: Review of Management and Long-term Outcome. Current Pediatrics Reports (2020) 8:16–25. 
2. Cody EM, Dixon BP. Hemolytic uremic syndrome. Pediatr Clin North Am. 2019; 66:235–246.
3. Gisaru S. Associations between hydration status, intravenous fluid administration, and outcomes of patients infected with shiga toxin–producing Escherichia coli; A systematic review and meta-analysis.JAMA Pediatr. 2017; 171:68–76.
4. UpToDate. (2021). Overview of hemolytic uremic syndrome in children. Available from: https://www.uptodate.com/contents/overview-of-hemolytic-uremic-syndrome-in-children?search=hemolytic%20uremic%20syndrome&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1